I’ve heard the same thing.
It’s actually a problem since the medication is for diabetics which have led to a shortage (at least in the nordic countries) for those who actually need it.
I’ve heard the same thing.
It’s actually a problem since the medication is for diabetics which have led to a shortage (at least in the nordic countries) for those who actually need it.
It's also BIG business in the U.S.
https://athletechnews.com/jp-morgan-targets-weight-loss-drugs-with-500m-fund/